Clinical Trial: Treatment for Presumed Ocular Histoplasmosis
Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Intravitreal Aflibercept Injection for the Treatment of cHoroidAl Neovascularization seconDary to Presumed ocuLar Histoplasmosis syndromE.(the HANDLE Study)
Brief Summary: The purpose of this study is to monitor safety outcomes for patients being treated with intravitreal aflibercept injections for choroidal neovascularization secondary to Presumed Ocular Histoplasmosis Syndrome.
Detailed Summary:
Sponsor: John Kitchens, MD
Current Primary Outcome: ocular and systemic adverse events [ Time Frame: through Month 12 ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Visual acuity [ Time Frame: Months 3, 6, 9 and 12 ]
- Mean change in BCVA from Baseline
- Proportion of subjects gaining >5,10 and 15 letters
- Proportion of subjects losing >5, 10 and 15 letters
Original Secondary Outcome: Same as current
Information By: Retina Associates of Kentucky
Dates:
Date Received: February 11, 2013
Date Started: March 2013
Date Completion: August 2014
Last Updated: June 13, 2014
Last Verified: June 2014